Evidence map›Paper›PMID 41458747›Full record

ReviewCureus2025

Harnessing Artificial Intelligence for Precision Cardiovascular Medicine.

Arijita Banerjee, Pradosh Kumar Sarangi

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arijita BanerjeePhysiology, Indian Institute of Technology, Kharagpur, West Bengal, IND.
Pradosh Kumar SarangiRadiodiagnosis, All India Institute of Medical Sciences, Deoghar, Rampur, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) has revolutionized cardiology diagnostic capabilities by improving precision, effectiveness, and prompt identification of various cardiac diseases. AI subfields include machine learning, deep learning, and cognitive computing. Machine learning can be supervised, unsupervised, or reinforcement learning. Support vector machines (SVM), deep learning, and artificial neural networks (ANN) are commonly used in the medical field for handling large and complex data. ANNs perform better than SVMs in evaluating electrocardiogram (ECG) data, while SVMs are used for disease stratification. AI-driven diagnostic tools have transformed the interpretation of ECGs, echocardiograms, cardiac imaging, and other diagnostic modalities, leading to better patient outcomes and more accurate clinical decision-making. AI has shown promise in identifying and describing coronary artery disease, with machine learning models training on cardiac CT images. Non-invasive AI tools, like HeartFlow, help patients with cardiac autonomic dysfunction (CAD) with treatment planning and decision-making. AI systems often require access to sensitive patient data, raising concerns about privacy, data security, and consent. Additionally, using patient data without clear ethical oversight may erode public trust. Transparency in how AI tools use and protect data is essential to maintain ethical standards in cardiovascular medicine.

Indexed as

arrythmiacardiac imagingdeep learningelectrocardiography (ecg)electronic health recordsmachine learningneural networks

Identifiers

PMID41458747
PMCPMC12741864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.